W. Schr�ter

463 total citations
31 papers, 361 citations indexed

About

W. Schr�ter is a scholar working on Physiology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, W. Schr�ter has authored 31 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 10 papers in Pediatrics, Perinatology and Child Health and 7 papers in Molecular Biology. Recurrent topics in W. Schr�ter's work include Erythrocyte Function and Pathophysiology (16 papers), Neonatal Health and Biochemistry (8 papers) and Blood disorders and treatments (4 papers). W. Schr�ter is often cited by papers focused on Erythrocyte Function and Pathophysiology (16 papers), Neonatal Health and Biochemistry (8 papers) and Blood disorders and treatments (4 papers). W. Schr�ter collaborates with scholars based in Germany, Israel and United Kingdom. W. Schr�ter's co-authors include Wolfgang Tillmann, Manfred Gahr, G. Prindull, Stefan Eber, M. Lakomek, Kathrin Becker, L. E. Feinendegen, K. Kasperek, I. Lombeck and H. J. Bremer and has published in prestigious journals such as Human Mutation, Human Genetics and Journal of Molecular Medicine.

In The Last Decade

W. Schr�ter

30 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Schr�ter Germany 9 166 98 79 77 62 31 361
L. Vettore Italy 13 225 1.4× 80 0.8× 31 0.4× 179 2.3× 102 1.6× 36 498
Jack M. Cooperman United States 12 53 0.3× 67 0.7× 73 0.9× 37 0.5× 81 1.3× 20 371
G. W. L�hr Germany 10 187 1.1× 109 1.1× 11 0.1× 55 0.7× 72 1.2× 17 325
G. W. L�hr Germany 9 180 1.1× 93 0.9× 10 0.1× 60 0.8× 94 1.5× 17 362
Fred J. Oelshlegel United States 9 87 0.5× 42 0.4× 120 1.5× 112 1.5× 58 0.9× 15 332
Gianfranco Gaetani Italy 7 169 1.0× 154 1.6× 12 0.2× 14 0.2× 118 1.9× 8 434
Robert G. Cheron United States 7 59 0.4× 76 0.8× 50 0.6× 184 2.4× 57 0.9× 9 497
H. D. Waller Germany 6 136 0.8× 65 0.7× 8 0.1× 33 0.4× 72 1.2× 10 270
Udo Wendel Germany 12 68 0.4× 55 0.6× 31 0.4× 30 0.4× 245 4.0× 18 525
Ernest Beutler United States 9 84 0.5× 116 1.2× 368 4.7× 434 5.6× 72 1.2× 10 652

Countries citing papers authored by W. Schr�ter

Since Specialization
Citations

This map shows the geographic impact of W. Schr�ter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Schr�ter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Schr�ter more than expected).

Fields of papers citing papers by W. Schr�ter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Schr�ter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Schr�ter. The network helps show where W. Schr�ter may publish in the future.

Co-authorship network of co-authors of W. Schr�ter

This figure shows the co-authorship network connecting the top 25 collaborators of W. Schr�ter. A scholar is included among the top collaborators of W. Schr�ter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Schr�ter. W. Schr�ter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kugler, Wilfried, Andreas Ohlenbusch, Petra Laspe, et al.. (2000). Eight novel mutations and consequences on mRNA and protein level in pyruvate kinase-deficient patients with nonspherocytic hemolytic anemia. Human Mutation. 15(3). 261–272. 16 indexed citations
2.
Kugler, Wilfried, Petra Laspe, Hilary Muirhead, et al.. (1998). Molecular basis of neurological dysfunction coupled with haemolytic anaemia in human glucose-6-phosphate isomerase (GPI) deficiency. Human Genetics. 103(4). 450–454. 45 indexed citations
3.
Pekrun, Arnulf, Stefan Eber, & W. Schr�ter. (1989). G6PD Avenches and G6PD Moosburg: biochemical and erythrocyte membrane characterization. Annals of Hematology. 58(1). 11–14. 4 indexed citations
4.
Eber, Stefan, et al.. (1988). Glucuronyl transferase deficiency and mild hereditary spherocytosis: effect of splenectomy. European Journal of Pediatrics. 147(6). 639–642. 1 indexed citations
5.
Eber, Stefan, Manfred Gahr, & W. Schr�ter. (1985). Glucose-6-phosphate dehydrogenase (G6PD) iserlohn and G6PD regensburg: Two new severe enzyme defects in german families. Annals of Hematology. 51(2). 109–115. 4 indexed citations
6.
Lakomek, M., H. Winkler, Wolfgang Tillmann, et al.. (1984). Erythrocyte pyruvate kinase deficiency: Characterization of a new variant (PK ?Aarau?). Annals of Hematology. 48(3). 123–129. 4 indexed citations
7.
Schr�ter, W., et al.. (1982). Hemoglobin biosynthesis in juvenile erythroleukemia: Evidence of imbalanced globin chain synthesis. Annals of Hematology. 44(1). 7–13. 1 indexed citations
8.
Prindull, G., et al.. (1982). A comparison of spontaneous and CSF added CFU-MG colony formation in healthy, sick and hypotrophic pre-term infants. Annals of Hematology. 45(3). 167–170. 2 indexed citations
9.
Schr�ter, W., et al.. (1982). Pyruvate kinase ?G�ttingen1,2?: Congenital hemolytic anemia, evidence of double heterozygosity, and lack of enzyme cooperativity. Human Genetics. 60(4). 381–386. 6 indexed citations
10.
Schr�ter, W.. (1980). Successful long-term phenobarbital therapy of hyperbilirubinemia in congenital hemolytic anemia due to glucose phosphate isomerase deficiency. European Journal of Pediatrics. 135(1). 41–43. 1 indexed citations
11.
Lakomek, M., W. Schr�ter, & H. Winkler. (1979). Kinetic measurements on the pyruvate kinase reaction in erythrocytes. Annals of Hematology. 38(2). 169–173. 1 indexed citations
12.
Schr�ter, W., et al.. (1978). Pyruvate kinase-catalyzed ATP-formation in human red blood cell membranes. Annals of Hematology. 37(1). 1–5. 3 indexed citations
13.
Gahr, Manfred, et al.. (1977). Biochemische Eigenschaften einer neuen Variante des Glucose-6-phosphatdehydrogenase (G-6-PD)-Mangels mit Favismus: G-6-PD Bielefeld. Journal of Molecular Medicine. 55(8). 379–384. 3 indexed citations
14.
Tillmann, Wolfgang, et al.. (1977). G�nstige rheologische Eigenschaften der Erythrozyten beim Glucose-6-phosphatdehydrogenase-Mangel. Journal of Molecular Medicine. 55(8). 385–391. 4 indexed citations
15.
Tillmann, Wolfgang, G. Prindull, & W. Schr�ter. (1976). Severe anemia due to transient pure red cell aplasia in early childhood. European Journal of Pediatrics. 123(1). 51–58. 7 indexed citations
16.
Schr�ter, W.. (1970). Transitorischer Pyruvatkinase- und Glutathionreductase-Mangel der Erythrocyten bei chronischer idiopathischer infantiler Pancytopenie. Journal of Molecular Medicine. 48(23). 1407–1414. 16 indexed citations
17.
Schr�ter, W.. (1970). Die Aktivit�t der UDP-Glucurons�urepyrophosphatase in der Leber w�hrend der Entwicklung. European Journal of Pediatrics. 108(2). 93–102. 1 indexed citations
18.
Schr�ter, W., et al.. (1970). Die Bedeutung der Glutathionkonzentration der Erythrocyten f�r die Diagnose der Osteomyelofibrose. Journal of Molecular Medicine. 48(16). 1013–1014. 4 indexed citations
19.
Schr�ter, W., et al.. (1965). Erythrocytenenzyme w�hrend der Entwicklung. European Journal of Pediatrics. 94(3). 263–273. 10 indexed citations
20.
Schr�ter, W., et al.. (1960). Zur Reindarstellung eines eisenbindenden Proteins in der Frauenmilch. Journal of Molecular Medicine. 38(22). 1162–1164. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026